BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: van der Geest KSM, Sandovici M, van Sleen Y, Sanders JS, Bos NA, Abdulahad WH, Stegeman CA, Heeringa P, Rutgers A, Kallenberg CGM, Boots AMH, Brouwer E. Review: What Is the Current Evidence for Disease Subsets in Giant Cell Arteritis? Arthritis Rheumatol 2018;70:1366-76. [PMID: 29648680 DOI: 10.1002/art.40520] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 8.5] [Reference Citation Analysis]
Number Citing Articles
1 van der Geest KSM, Sandovici M, Nienhuis PH, Slart RHJA, Heeringa P, Brouwer E, Jiemy WF. Novel PET Imaging of Inflammatory Targets and Cells for the Diagnosis and Monitoring of Giant Cell Arteritis and Polymyalgia Rheumatica. Front Med 2022;9:902155. [DOI: 10.3389/fmed.2022.902155] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 van Sleen Y, Therkildsen P, Nielsen BD, van der Geest KSM, Hansen I, Heeringa P, Posthumus MD, Sandovici M, Toonen EJM, Zijlstra J, Boots AMH, Hauge EM, Brouwer E. Angiopoietin-2/-1 ratios and MMP-3 levels as an early warning sign for the presence of giant cell arteritis in patients with polymyalgia rheumatica. Arthritis Res Ther 2022;24:65. [PMID: 35255968 DOI: 10.1186/s13075-022-02754-5] [Reference Citation Analysis]
3 Sandovici M, van der Geest N, van Sleen Y, Brouwer E. Need and value of targeted immunosuppressive therapy in giant cell arteritis. RMD Open 2022;8:e001652. [PMID: 35149602 DOI: 10.1136/rmdopen-2021-001652] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Gheysens O, Jamar F, Glaudemans AWJM, Yildiz H, van der Geest KSM. Semi-Quantitative and Quantitative [18F]FDG-PET/CT Indices for Diagnosing Large Vessel Vasculitis: A Critical Review. Diagnostics (Basel) 2021;11:2355. [PMID: 34943593 DOI: 10.3390/diagnostics11122355] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
5 Tomelleri A, van der Geest KSM, Sebastian A, van Sleen Y, Schmidt WA, Dejaco C, Dasgupta B. Disease stratification in giant cell arteritis to reduce relapses and prevent long-term vascular damage. The Lancet Rheumatology 2021;3:e886-95. [DOI: 10.1016/s2665-9913(21)00277-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Carvajal Alegria G, van Sleen Y, Graver JC, Sandovici M, Devauchelle-pensec V, Brouwer E, Cornec D. Atteinte de l’aorte dans l’artérite à cellules géantes. Revue du Rhumatisme 2021;88:405-409. [DOI: 10.1016/j.rhum.2021.05.003] [Reference Citation Analysis]
7 Esen I, Jiemy WF, van Sleen Y, van der Geest KSM, Sandovici M, Heeringa P, Boots AMH, Brouwer E. Functionally Heterogenous Macrophage Subsets in the Pathogenesis of Giant Cell Arteritis: Novel Targets for Disease Monitoring and Treatment. J Clin Med 2021;10:4958. [PMID: 34768479 DOI: 10.3390/jcm10214958] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
8 Tsuzuki S, Tsuchiya H, Shoda H, Fujio K. Orbital apex syndrome on initial presentation of giant cell arteritis: a case report and review of the literature. Scand J Rheumatol 2021;:1-2. [PMID: 34698002 DOI: 10.1080/03009742.2021.1975395] [Reference Citation Analysis]
9 Robson JC, Almeida C, Dawson J, Bromhead A, Dures E, Guly C, Hoon E, Mackie S, Ndosi M, Pauling J, Hill C. Patient perceptions of health-related quality of life in giant cell arteritis: international development of a disease-specific patient-reported outcome measure. Rheumatology (Oxford) 2021;60:4671-80. [PMID: 33528002 DOI: 10.1093/rheumatology/keab076] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
10 Gazzito Del Padre TC, Belem JMFM, de Aguiar MF, Torquato HFV, Paredes-Gamero EJ, Abdulahad WH, Brouwer E, de Souza AWS. Distribution of monocytes subpopulations in the peripheral blood from patients with Behçet's disease - Impact of disease status and colchicine use. Clin Immunol 2021;231:108854. [PMID: 34530137 DOI: 10.1016/j.clim.2021.108854] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
11 Vrinceanu D, Dumitru M, Banica B, Eftime IS, Patrascu O, Costache A, Cherecheanu MP, Georgescu MG. Role of temporal artery resection in Horton's arteritis (Review). Exp Ther Med 2021;22:1099. [PMID: 34504553 DOI: 10.3892/etm.2021.10533] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Aussedat M, Lobbes H, Samson M, Euvrard R, Lega JC, Mainbourg S. Epidemiology of major relapse in giant cell arteritis: A study-level meta-analysis. Autoimmun Rev 2021;:102930. [PMID: 34481940 DOI: 10.1016/j.autrev.2021.102930] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
13 Prieto-Peña D, Castañeda S, Martínez-Rodríguez I, Atienza-Mateo B, Blanco R, González-Gay MA. Imaging Tests in the Early Diagnosis of Giant Cell Arteritis. J Clin Med 2021;10:3704. [PMID: 34442002 DOI: 10.3390/jcm10163704] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
14 Palamidas DA, Argyropoulou OD, Georgantzoglou N, Karatza E, Xingi E, Kapsogeorgou EK, Anagnostopoulos CD, Lazaris AC, Ritis K, Goules AV, Kambas K, Tzioufas AG. Neutrophil extracellular traps in giant cell arteritis biopsies: presentation, localization and co-expression with inflammatory cytokines. Rheumatology (Oxford) 2021:keab505. [PMID: 34260696 DOI: 10.1093/rheumatology/keab505] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
15 Reitsema RD, Boots AMH, van der Geest KSM, Sandovici M, Heeringa P, Brouwer E. CD8+ T Cells in GCA and GPA: Bystanders or Active Contributors? Front Immunol 2021;12:654109. [PMID: 33815414 DOI: 10.3389/fimmu.2021.654109] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Karabayas M. Comment on: Evaluation of adjunctive mycophenolate for large vessel giant cell arteritis. Reply. Rheumatol Adv Pract 2021;5:rkab012. [PMID: 33796814 DOI: 10.1093/rap/rkab012] [Reference Citation Analysis]
17 van der Geest KSM, Wolfe K, Borg F, Sebastian A, Kayani A, Tomelleri A, Gondo P, Schmidt WA, Luqmani R, Dasgupta B. Ultrasonographic Halo Score in giant cell arteritis: association with intimal hyperplasia and ischaemic sight loss. Rheumatology (Oxford) 2020:keaa806. [PMID: 33355340 DOI: 10.1093/rheumatology/keaa806] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
18 Schmidt WA, Nielsen BD. Imaging in large-vessel vasculitis. Best Practice & Research Clinical Rheumatology 2020;34:101589. [DOI: 10.1016/j.berh.2020.101589] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
19 Reitsema RD, Hid Cadena R, Nijhof SH, Abdulahad WH, Huitema MG, Paap D, Brouwer E, Boots AMH, Heeringa P. Effect of age and sex on immune checkpoint expression and kinetics in human T cells. Immun Ageing 2020;17:32. [PMID: 33292359 DOI: 10.1186/s12979-020-00203-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
20 Prieto-peña D, Remuzgo-martínez S, Ocejo-vinyals JG, Atienza-mateo B, Muñoz-jiménez A, Ortiz-sanjuán F, Romero-yuste S, Moriano C, Galíndez-agirregoikoa E, Miranda-filloy JA, Blanco R, Gualillo O, Martín J, Castañeda S, López-mejías R, González-gay MA. Cranial and extracranial giant cell arteritis share similar HLA-DRB1 association. Seminars in Arthritis and Rheumatism 2020;50:897-901. [DOI: 10.1016/j.semarthrit.2020.07.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
21 Liozon E, Dumonteil S, Parreau S, Gondran G, Bezanahary H, Palat S, Ly KH, Fauchais AL. Risk profiling for a refractory course of giant cell arteritis: The importance of age and body weight: "Risk profiling for GC resistance in GCA". Semin Arthritis Rheum 2020;50:1252-61. [PMID: 33065420 DOI: 10.1016/j.semarthrit.2020.09.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Sebastian A, van der Geest KSM, Coath F, Gondo P, Kayani A, Mackerness C, Hadebe B, Innes S, Jackson J, Dasgupta B. Halo score (temporal artery, its branches and axillary artery) as a diagnostic, prognostic and disease monitoring tool for Giant Cell Arteritis (GCA). BMC Rheumatol 2020;4:35. [PMID: 32821876 DOI: 10.1186/s41927-020-00136-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
23 Carvajal Alegria G, van Sleen Y, Graver JC, Sandovici M, Devauchelle-Pensec V, Brouwer E, Cornec D. Aortic involvement in giant cell arteritis. Joint Bone Spine 2021;88:105045. [PMID: 32649986 DOI: 10.1016/j.jbspin.2020.06.018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 van Sleen Y, Boots AMH, Abdulahad WH, Bijzet J, Sandovici M, van der Geest KSM, Brouwer E. High angiopoietin-2 levels associate with arterial inflammation and long-term glucocorticoid requirement in polymyalgia rheumatica. Rheumatology (Oxford) 2020;59:176-84. [PMID: 31292652 DOI: 10.1093/rheumatology/kez261] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
25 Gribbons KB, Ponte C, Craven A, Robson JC, Suppiah R, Luqmani R, Watts R, Merkel PA, Grayson PC. Diagnostic Assessment Strategies and Disease Subsets in Giant Cell Arteritis: Data From an International Observational Cohort. Arthritis Rheumatol 2020;72:667-76. [PMID: 31729185 DOI: 10.1002/art.41165] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 8.5] [Reference Citation Analysis]
26 Bunting E, Barritt AW, Leigh N, Wright D, Rashid W; Brighton and Sussex University NHS Trust, Royal Sussex County Hospital. An atypical presentation of giant cell arteritis without headache. ACNR 2020;20:23-5. [DOI: 10.47795/amba7231] [Reference Citation Analysis]
27 van der Geest KSM, Borg F, Kayani A, Paap D, Gondo P, Schmidt W, Luqmani RA, Dasgupta B. Novel ultrasonographic Halo Score for giant cell arteritis: assessment of diagnostic accuracy and association with ocular ischaemia. Ann Rheum Dis 2020;79:393-9. [PMID: 31900304 DOI: 10.1136/annrheumdis-2019-216343] [Cited by in Crossref: 47] [Cited by in F6Publishing: 51] [Article Influence: 23.5] [Reference Citation Analysis]
28 Agard C, Bonnard G, Samson M, de Moreuil C, Lavigne C, Jégo P, Connault J, Artifoni M, Le Gallou T, Landron C, Roblot P, Magnant J, Belizna C, Maillot F, Diot E, Néel A, Hamidou M, Espitia O. Giant cell arteritis-related aortitis with positive or negative temporal artery biopsy: a French multicentre study. Scand J Rheumatol 2019;48:474-81. [PMID: 31766965 DOI: 10.1080/03009742.2019.1661011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
29 Dardick JM, Esenwa CC, Zampolin RL, Ustun B, Ayesha B, Kirchoff-Torres KF, Liberman AL. Acute Lateral Medullary Infarct due to Giant Cell Arteritis: A Case Study. Stroke 2019;50:e290-3. [PMID: 31495325 DOI: 10.1161/STROKEAHA.119.026566] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
30 Chean CS, Prior JA, Helliwell T, Belcher J, Mackie SL, Hider SL, Liddle J, Mallen CD. Characteristics of patients with giant cell arteritis who experience visual symptoms. Rheumatol Int 2019;39:1789-96. [PMID: 31440812 DOI: 10.1007/s00296-019-04422-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
31 Hid Cadena R, Reitsema RD, Huitema MG, van Sleen Y, van der Geest KSM, Heeringa P, Boots AMH, Abdulahad WH, Brouwer E. Decreased Expression of Negative Immune Checkpoint VISTA by CD4+ T Cells Facilitates T Helper 1, T Helper 17, and T Follicular Helper Lineage Differentiation in GCA. Front Immunol 2019;10:1638. [PMID: 31379838 DOI: 10.3389/fimmu.2019.01638] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
32 Mestre-torres J, Simó-perdigó M, Martínez-valle F, Navales I, Loureiro-amigo J, Solans-laque R. Risk of ischaemic events at giant cell arteritis diagnosis according to PET/CT findings. Eur J Nucl Med Mol Imaging 2019;46:1626-32. [DOI: 10.1007/s00259-019-04339-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
33 van Sleen Y, Sandovici M, Abdulahad WH, Bijzet J, van der Geest KSM, Boots AMH, Brouwer E. Markers of angiogenesis and macrophage products for predicting disease course and monitoring vascular inflammation in giant cell arteritis. Rheumatology (Oxford) 2019:kez034. [PMID: 30805622 DOI: 10.1093/rheumatology/kez034] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 9.7] [Reference Citation Analysis]